Evaluation of cytotoxicity, immune compatibility and antibacterial activity of biogenic silver nanoparticles

Medical Microbiology and Immunology

Volumn 205, Issue 6, 2016, Pages 603-613

  Skladanowski M ^a   Golinska, P ^a   Rudnicka, K ^b   Dahm, H ^a   Rai, M ^c  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Actinomycetes; Antibacterial activity; Biogenic silver nanoparticles; Cytotoxicity; NF B activation

Indexed keywords

BIOGENIC SILVER NANOPARTICLE; SILVER NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; METAL NANOPARTICLE; SILVER;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOCOMPATIBILITY; BIOSYNTHESIS; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; ESCHERICHIA COLI; FIBROBLAST CULTURE; GENE SEQUENCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IC50; IN VITRO STUDY; INFRARED SPECTROSCOPY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR INFANTIS; SEQUENCE HOMOLOGY; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL; ANIMAL; BACTERIUM; CELL LINE; CHEMISTRY; DRUG EFFECTS; HUMAN; IMMUNOLOGY; MICROBIAL SENSITIVITY TEST; ULTRASTRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; CELL LINE; HUMANS; METAL NANOPARTICLES; MICE; MICROBIAL SENSITIVITY TESTS; SILVER; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84987606059     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-016-0477-7     Document Type: Article

References (70)

1. Rai MK, Deshmukh SD, Ingle AP, Gade AK (2012) Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 112:841–852. doi:10.1111/j.1365-2672.2012.05253.x
2. Ahmad A, Mukherjee P, Senapati S et al (2012) Extracellular biosynthesis of platinum nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B Biointerfaces 97:27–31. doi:10.1016/j.colsurfb.2012.03.026
3. Gopinath PM, Narchonai G, Dhanasekaran D et al (2015) Mycosynthesis, characterization and antibacterial properties of AgNPs against multidrug resistant (MDR) bacterial pathogens of female infertility cases. Asian J Pharm Sci 10:138–145. doi:10.1016/j.ajps.2014.08.007
4. Zhou Y, Kong Y, Kundu S et al (2012) Antibacterial activities of gold and silver nanoparticles against Escherichia coli and bacillus Calmette-Guerin. J Nanobiotechnol 10:19. doi:10.1186/1477-3155-10-19
5. Lara HH, Ixtepan-Turrent L, Garza Treviño EN, Singh DK (2011) Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins. J Nanobiotechnol 9:38. doi:10.1186/1477-3155-9-38
6. Guo D, Zhu L, Huang Z et al (2013) Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 34:7884–7894. doi:10.1016/j.biomaterials.2013.07.015
7. Austin LA, Kang B, Yen C-W, El-Sayed M (2011) Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. Bioconjug Chem 22:2324–2331. doi:10.1021/bc200386m
8. Greulich C, Diendorf J, Simon T et al (2011) Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7:347–354. doi:10.1016/j.actbio.2010.08.003
9. Liz R, Simard J, Bruna L et al (2015) Silver nanoparticles rapidly induce atypical human neutrophil cell death by a process involving inflammatory caspases and reactive oxygen species and induce neutrophil extracellular traps release upon cell adhesion. Int Immunopharmacol 28:616–625. doi:10.1016/j.intimp.2015.06.030
10. Chairuangkitti P, Lawanprasert S, Roytrakul S et al (2012) Silver nanoparticles induce toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicol Vitr 27:330–338. doi:10.1016/j.tiv.2012.08.021
11. Zhang T, Wang L, Chen Q, Chen C (2014) Cytotoxic potential of silver nanoparticles. Yonsei Med J 55:283–291. doi:10.3349/ymj.2014.55.2.283
12. Fu PP, Xia Q, Hwang H et al (2014) Mechanisms of nanotoxicity: generation of reactive oxygen species. J Food Drug Anal 22:64–75. doi:10.1016/j.jfda.2014.01.005
13. Thaiss CA, Levy M, Itav S, Elinav E (2016) Integration of innate immune signaling. Trends Immunol 37:1–18. doi:10.1016/j.it.2015.12.003
14. Druszczynska M, Wlodarczyk M, Janiszewska-Drobinska B et al (2013) Monocyte signal transduction receptors in active and latent tuberculosis. Clin Dev Immunol. doi:10.1155/2013/851452
15. Küster E, Williams ST (1964) Selection of media for isolation of Streptomycetes. Nature 202:928–929
16. Golinska P, Wang D, Goodfellow M (2013) Nocardia aciditolerans sp. nov., isolated from a spruce forest soil. Antonie Van Leeuwenhoek 103:1079–1088. doi:10.1007/s10482-013-9938-9
17. Kim O-S, Cho Y-J, Lee K et al (2012) Introducing EzTaxon-e: a prokaryotic 16S rRNA gene sequence database with phylotypes that represent uncultured species. Int J Syst Evol Microbiol 62:716–721. doi:10.1099/ijs.0.038075-0
18. Manivasagan P, Venkatesan J, Senthilkumar K et al (2013) Biosynthesis, antimicrobial and cytotoxic effect of silver nanoparticles using a novel Nocardiopsis sp. MBRC-1. Biomed Res Int. doi:10.1155/2013/287638
19. Chauhan R, Kumar A, Abraham J (2013) A biological approach to the synthesis of silver nanoparticles with Streptomyces sp JAR1 and its antimicrobial activity. Sci Pharm 81:607–621. doi:10.3797/scipharm.1302-02
20. Bindhu MR, Umadevi M (2014) Surface plasmon resonance optical sensor and antibacterial activities of biosynthesized silver nanoparticles. Spectrochim Acta Part A Mol Biomol Spectrosc 121:596–604. doi:10.1016/j.saa.2013.11.019
21. Subashini J, Kannabiran K (2013) Antimicrobial activity of Streptomyces sp. VITBT7 and its synthesized silver nanoparticles against medically important fungal and bacterial pathogens. Der Pharm Lett 5:192–200
22. Abdeen S, Geo S, Sukanya et al (2014) Biosynthesis of silver nanoparticles from Actinomycetes for therapeutic applications. Int J Nano Dimens 5:155–162
23. Karthik L, Kumar G, Kirthi AV et al (2014) Streptomyces sp. LK3 mediated synthesis of silver nanoparticles and its biomedical application. Bioprocess Biosyst Eng 37:261–267. doi:10.1007/s00449-013-0994-3
24. Montes-Burgos I, Walczyk D, Hole P et al (2010) Characterisation of nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res 12:47–53. doi:10.1007/s11051-009-9774-z
25. Anasane N, Golińska P, Wypij M et al (2015) Acidophilic actinobacteria synthesised silver nanoparticles showed remarkable activity against fungi-causing superficial mycoses in humans. Mycoses 59:157–166. doi:10.1111/myc.12445
26. Gurunathan S, Jeong J-K, Han JW et al (2015) Multidimensional effects of biologically synthesized silver nanoparticles in Helicobacter pylori, Helicobacter felis, and human lung (L132) and lung carcinoma A549 cells. Nanoscale Res Lett 10:35. doi:10.1186/s11671-015-0747-0
27. Jeevan P, Ramya K, Rena AE (2012) Extracellular biosynthesis of silver nanoparticles by culture supernatant of Pseudomonas aeruginosa. Indian J Biotechnol 11:72–76
28. Ramezani F, Jebali A, Kazemi B (2012) A green approach for synthesis of gold and silver nanoparticles by Leishmania sp. Appl Biochem Biotechnol 168:1549–1555. doi:10.1007/s12010-012-9877-3
29. Faramarzi MA, Forootanfar H (2011) Biosynthesis and characterization of gold nanoparticles produced by laccase from Paraconiothyrium variabile. Colloids Surf B Biointerfaces 87:23–27. doi:10.1016/j.colsurfb.2011.04.022
30. Chao Y, Makale M, Karmali PP et al (2012) Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. Bioconjug Chem 23:1003–1009. doi:10.1021/bc200685a
31. Gole A, Dash C, Ramakrishnan V et al (2001) Pepsin-gold colloid conjugates: preparation, characterization, and enzymatic activity. Langmuir 17:1674–1679. doi:10.1021/la001164w
32. Nachiyar V, Sunkar S, Prakash P (2015) Biological synthesis of gold nanoparticles using endophytic fungi. Der Pharma Chem 7:31–38
33. Logeswari P, Silambarasan S, Abraham J (2013) Ecofriendly synthesis of silver nanoparticles from commercially available plant powders and their antibacterial properties. Sci Iran 20:1049–1054. doi:10.1016/j.scient.2013.05.016
34. Kaler A, Jain S, Banerjee UC (2013) Green and rapid synthesis of anticancerous silver nanoparticles by Saccharomyces boulardii and insight into mechanism of nanoparticle synthesis. Biomed Res Int. doi:10.1155/2013/872940
35. Muthuvel A, Adavallan K, Balamurugan K, Krishnakumar N (2014) Biosynthesis of gold nanoparticles using Solanum nigrum leaf extract and screening their free radical scavenging and antibacterial properties. Biomed Prev Nutr 4:325–332. doi:10.1016/j.bionut.2014.03.004
36. Golińska P, Wypij M, Rathod D et al (2015) Synthesis of silver nanoparticles from two acidophilic strains of Pilimelia columellifera subsp. pallida and their antibacterial activities. J Basic Microbiol 55:1–16. doi:10.1002/jobm.201500516
37. Li WR, Xie XB, Shi QS et al (2010) Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. Appl Microbiol Biotechnol 85:1115–1122. doi:10.1007/s00253-009-2159-5
38. Ansari MA, Khan HM, Khan AA et al (2011) Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections. Biol Med 3:141–146
39. Sivalingam P, Antony JJ, Siva D et al (2012) Mangrove Streptomyces sp. BDUKAS10 as nanofactory for fabrication of bactericidal silver nanoparticles. Colloids Surf B Biointerfaces 98:12–17. doi:10.1016/j.colsurfb.2012.03.032
40. Yakout SM, Mostafa AA (2015) A novel green synthesis of silver nanoparticles using soluble starch and its antibacterial activity. Int J Clin Exp Med 8:3538–3544
41. Paredes D, Ortiz C, Torres R (2014) Synthesis, characterization, and evaluation of antibacterial effect of Ag nanoparticles against Escherichia coli O157:H7 and methicillin-resistant Staphylococcus aureus (MRSA). Int J Nanomedicine 9:1717–1729. doi:10.2147/IJN.S57156
42. Zarei M, Jamnejad A, Khajehali E (2014) Antibacterial effect of silver nanoparticles against four foodborne pathogens. Jundishapur J Microbiol 7:1–4. doi:10.5812/jjm.8720
43. Singh R, Wagh P, Wadhwani S et al (2013) Synthesis, optimization, and characterization of silver nanoparticles from Acinetobacter calcoaceticus and their enhanced antibacterial activity when combined with antibiotics. Int J Nanomed 8:4277–4290. doi:10.2147/IJN.S48913
44. Chudasama B, Vala AK, Andhariya N et al (2010) Highly bacterial resistant silver nanoparticles: synthesis and antibacterial activities. J Nanopart Res 12:1677–1685. doi:10.1007/s11051-009-9845-1
45. Durán N, Marcato PD, De Conti R et al (2010) Potential use of silver nanoparticles on pathogenic bacteria, their toxicity and possible mechanisms of action. J Braz Chem Soc 21:949–959. doi:10.1590/S0103-50532010000600002
46. de Lima R, Seabra AB, Durán N (2012) Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol 32:867–879. doi:10.1002/jat.2780
47. Kim JS, Kuk E, Yu KN et al (2007) Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 3:95–101. doi:10.1016/j.nano.2006.12.001
48. McShan D, Ray PC, Yu H (2014) Molecular toxicity mechanism of nanosilver. J Food Drug Anal 22:116–127. doi:10.1016/j.jfda.2014.01.010
49. Pal R, Bhattacharyya P, Das P et al (2007) Relationship between acidity and microbiological properties in some tea soils. Biol Fertil Soils 44:399–404. doi:10.1007/s00374-007-0223-9
50. Louise Meyer R, Zhou X, Tang L et al (2010) Immobilisation of living bacteria for AFM imaging under physiological conditions. Ultramicroscopy 110:1349–1357. doi:10.1016/j.ultramic.2010.06.010
51. Choi O, Hu Z (2008) Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ Sci Technol 42:4583–4588. doi:10.1021/es703238h
52. Das B, Dash SK, Mandal D et al (2015) Green synthesized silver nanoparticles destroy multidrug resistant bacteria via reactive oxygen species mediated membrane damage. Arab J Chem. doi:10.1016/j.arabjc.2015.08.008
53. Jacobson KH, Gunsolus IL, Melby ES et al (2015) Lipopolysaccharide density and structure govern the extent and distance of nanoparticle interaction with actual and model bacterial outer membranes. Env Sci Technol 73:389–400. doi:10.1530/ERC-14-0411.Persistent
54. Arora S, Jain J, Rajwade JM, Paknikar KM (2008) Cellular responses induced by silver nanoparticles: in vitro studies. Toxicol Lett 179:93–100. doi:10.1016/j.toxlet.2008.04.009
55. Carlson C, Hussein SM, Schrand AM et al (2008) Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B 112:13608–13619. doi:10.1021/jp712087m
56. Zhao W, Lu X, Yuan Y et al (2011) Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines. Int J Nanomed 6:1569–1577. doi:10.2147/IJN.S21373
57. Barua S, Konwarh R, Bhattacharya SS et al (2013) Non-hazardous anticancerous and antibacterial colloidal “green” silver nanoparticles. Colloids Surf B Biointerfaces 105:37–42. doi:10.1016/j.colsurfb.2012.12.015
58. Pastorelli L, De Salvo C, Mercado JR et al (2013) Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Front Immunol 4:1–22. doi:10.3389/fimmu.2013.00280
59. Navarro E, Baun A, Behra R et al (2008) Environmental behavior and ecotoxicity of engineered nanoparticles to algae, plants, and fungi. Ecotoxicology 17:372–386. doi:10.1007/s10646-008-0214-0
60. Rathod D, Golinska P, Wypij M, Dahm H, Rai M (2016) A new report of Nocardiopsis valliformis strain OT1 from alkaline Lonar crater of India and its use in synthesis of silver nanoparticles with special reference to evaluation of antibacterial activity and cytotoxicity. Med Microbiol Immunol 205:435–447. doi:10.1007/s00430-016-0462-1
61. Panda KK, Achary VMM, Krishnaveni R et al (2011) In vitro biosynthesis and genotoxicity bioassay of silver nanoparticles using plants. Toxicol Vitr 25:1097–1105. doi:10.1016/j.tiv.2011.03.008
62. Foldbjerg R, Dang DA, Autrup H (2011) Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–750. doi:10.1007/s00204-010-0545-5
63. Piao MJ, Kang KA, Lee IK et al (2011) Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol Lett 201:92–100. doi:10.1016/j.toxlet.2010.12.010
64. Sanpui P, Chattopadhyay A, Ghosh SS (2011) Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using chitosan nanocarrier. ACS Appl Mater Interfaces 3:218–228. doi:10.1021/am100840c
65. Shahbazzadeh D, Ahari H, Motalebi A (2011) In vitro effect of nanosilver toxicity on fibroblast and mesenchymal stem cell lines. Iran J Fish Sci 10:487–496
66. Stepkowski TM, Brzóska K, Kruszewski M (2014) Silver nanoparticles induced changes in the expression of NF-κB related genes are cell type specific and related to the basal activity of NF-κB. Toxicol Vitr 28:473–478. doi:10.1016/j.tiv.2014.01.008
67. Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1:1–10. doi:10.1101/cshperspect.a001651
68. Monteiller C, Tran L, MacNee W et al (2007) The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup Environ Med 64:609–615. doi:10.1136/oem.2005.024802
69. Khanna P, Ong C, Bay B, Baeg G (2015) Nanotoxicity: an interplay of oxidative stress, inflammation and cell death. Nanomaterials 5:1163–1180. doi:10.3390/nano5031163
70. Shi J, Sun X, Lin Y et al (2014) Endothelial cell injury and dysfunction induced by silver nanoparticles through oxidative stress via IKK/NF-κB pathways. Biomaterials 35:6657–6666. doi:10.1016/j.biomaterials.2014.04.093